Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma.

Eye (London, England)·2026
Same author

Tissue resident memory T cells populate the human uveal tract.

Scientific reports·2026
Same author

Preserflo microshunt in a real-life UK tertiary setting: success rates, safety profile, and postoperative management.

International ophthalmology·2026
Same author

A Prospective, Real-World, Multicenter Study to Support the Role of Ab-Interno Canaloplasty in Glaucoma Management.

American journal of ophthalmology·2026
Same author

Novel surgical implants in the treatment of childhood glaucoma.

Current opinion in ophthalmology·2025
Same author

Correction: In vitro flow properties of Preserflo Microshunt with an intraluminal stent.

Eye (London, England)·2025

Related Experiment Videos

Nonpenetrating glaucoma surgery: a critical evaluation.

Usman Sarodia1, Tarek Shaarawy, Keith Barton

  • 1Glaucoma Service, Moorfields Eye Hospital, London, UK.

Current Opinion in Ophthalmology
|February 16, 2007
PubMed
Summary

Nonpenetrating glaucoma surgery offers a potentially safer alternative to mitomycin-C trabeculectomy, with recent modifications improving intraocular pressure control. However, long-term efficacy compared to trabeculectomy remains uncertain.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Management

Background:

  • Nonpenetrating glaucoma surgery is favored globally for its perceived safety advantages over mitomycin-C trabeculectomy.
  • This review critically examines recent advancements and evidence concerning nonpenetrating glaucoma surgical techniques.

Purpose of the Study:

  • To evaluate the current literature on nonpenetrating glaucoma surgery.
  • To compare its safety and efficacy against mitomycin-C trabeculectomy.

Main Methods:

  • Literature review of recently published studies on nonpenetrating glaucoma surgery.
  • Analysis of comparative studies and randomized trials.

Main Results:

  • Modifications like implants, antiproliferative augmentation, and laser goniopuncture enhance intraocular pressure control.
  • Nonpenetrating glaucoma surgery shows a better safety profile but potentially higher long-term intraocular pressure than trabeculectomy.
  • Conclusive evidence of clinically significant differences in long-term intraocular pressure control between modified nonpenetrating glaucoma surgery and mitomycin-C trabeculectomy is lacking.

Conclusions:

  • Nonpenetrating glaucoma surgery is evolving with techniques showing improved efficacy.
  • The long-term intraocular pressure-lowering effect and its comparison to trabeculectomy require further investigation.